SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Chemed Corp – ‘8-K’ for 3/13/20

On:  Friday, 3/13/20, at 11:49am ET   ·   For:  3/13/20   ·   Accession #:  19584-20-9   ·   File #:  1-08351

Previous ‘8-K’:  ‘8-K’ on / for 2/18/20   ·   Next:  ‘8-K’ on / for 4/15/20   ·   Latest:  ‘8-K’ on / for 4/17/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/13/20  Chemed Corp                       8-K:8,9     3/13/20   11:212K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     30K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     10K 
 8: R1          Document And Entity Information                     HTML     47K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
10: XML         XBRL Instance -- che-20200313x8k_htm                 XML     15K 
 6: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- che-20200313_lab                      XML     56K 
 5: EX-101.PRE  XBRL Presentations -- che-20200313_pre               XML     32K 
 3: EX-101.SCH  XBRL Schema -- che-20200313                          XSD     11K 
 7: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
11: ZIP         XBRL Zipped Folder -- 0000019584-20-000009-xbrl      Zip     11K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C: 
  che-20200313x8k  
 i false i 000001958400000195842020-03-132020-03-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM  i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

 i March 13, 2020

 i CHEMED CORPORATION

(Exact name of registrant as specified in its charter)

 i Delaware

      i 1-8351

   i 31-0791746

(State or other
jurisdiction of
incorporation)

(Commission File Number)

(I.R.S. Employer
Identification
Number)

 i 2600 First Financial Center, 255 East 5th Street,  i Cincinnati,  i OH  i 45202

(Address of principal executive offices)             (Zip Code)

Registrant's telephone number, including area code:

( i 513)  i 762-6690

 

Title of each class

 

Trading symbol

Name of each exchange on which

registered

 i Capital stock $1 par value

 i CHE

 i NYSE

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 i [_]     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 i [_]     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)

 i [_]     Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b))

 i [_]     Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.  Emerging growth company  i [_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_]

Page 1 of 3


Item 8.01 Other Events

Chemed Corporation issued a press release announcing that on March 13, 2020, its Board of Directors increased the authorization of Chemed’s share repurchase program to provide for $250 million of future share repurchases. These will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.

A copy of the release is furnished herewith as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits

d)

Exhibits

 

 

 

 

 

(99.1) Registrant’s press release dated March 13, 2020

 

 

Page 2 of 3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHEMED CORPORATION

Dated:   March 13, 2020

By:

/s/ Michael D. Witzeman

Michael D. Witzeman

Vice President and Controller

Page 3 of 3


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:3/13/20None on these Dates
 List all Filings 
Top
Filing Submission 0000019584-20-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 6:13:29.1am ET